PCI Biotech Holding ASA (STU:4QG)
€ 0.1088 -0.0072 (-6.21%) Market Cap: 5.10 Mil Enterprise Value: 2.59 Mil PE Ratio: 0 PB Ratio: 1.76 GF Score: 39/100

Q3 2020 PCI Biotech Holding ASA Earnings Call Transcript

Nov 11, 2020 / 07:30AM GMT
Release Date Price: €2.03 (+1.50%)
Per Walday
PCI Biotech Holding ASA - CEO

Good morning, and welcome to PCI Biotech's Third Quarter Presentation 2020. My name is Per Walday. I am the CEO of PCI Biotech. I have also with me Ronny Skuggedal, who is the CFO of PCI Biotech.

We will start this presentation with a quick reminder of what PCI Biotech is, a company overview, before going into the highlights of the quarter. We will thereafter go a bit deeper into all the different programs and end with the outlook at the end. And then after the presentation, we will have -- there is an opportunity to put in questions through a link in the webcast, and we will start by reviewing those questions.

We have now, also for this presentation, started with a new facility, which is a phone conference. It's not just a webcast. It's also a phone conference. And that is primarily to let people call in and ask verbal questions directly to us at the end of this presentation. So please use this facility to -- if you want to ask verbal questions at the end of the presentation.

So with that, let me start by just reviewing PCI Biotech,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot